肺弥散功能在慢性阻塞性肺疾病中的进展
The Progression of Pulmonary Diffusion Function in Chronic Obstructive Pulmonary Disease
DOI: 10.12677/acm.2025.1582323, PDF,   
作者: 杨 丹：延安大学医学院，陕西 延安；贾建厚*：延安大学咸阳医院呼吸与危重症医学科，陕西 咸阳
关键词: 慢性阻塞性肺疾病；肺弥散功能；早期诊断；预后；Chronic Obstructive Pulmonary Disease； Pulmonary Diffusion Function； Early Diagnosis； Prognosis
摘要: 慢性阻塞性肺疾病(COPD)是一种常见的呼吸系统慢性炎症性疾病，其特征是持续性的气流受限。肺功能测试是诊断COPD的金标准，包括肺通气功能测试和肺弥散功能测试。近年来，多项研究揭示了肺弥散功能在COPD中的临床应用潜力，特别是在早期诊断、疾病评估以及预测死亡风险方面。本文旨在探讨肺弥散功能在COPD诊断和治疗中的作用，并对其预后进行进一步的探讨。
Abstract: Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease of respiratory system, which is characterized by persistent airflow limitation. Pulmonary function test is the gold standard for the diagnosis of COPD, including pulmonary ventilation function test and pulmonary diffusion function test. In recent years, many studies have revealed the clinical application potential of pulmonary diffusion function in COPD, especially in early diagnosis, disease evaluation and prediction of death risk. This paper aims to explore the role of pulmonary diffusion function in the diagnosis and treatment of COPD, and further explore its prognosis.
文章引用：杨丹, 贾建厚. 肺弥散功能在慢性阻塞性肺疾病中的进展[J]. 临床医学进展, 2025, 15(8): 974-977. https://doi.org/10.12677/acm.2025.1582323

参考文献

[1] Christenson, S.A., Smith, B.M., Bafadhel, M. and Putcha, N. (2022) Chronic Obstructive Pulmonary Disease. The Lancet, 399, 2227-2242. [Google Scholar] [CrossRef] [PubMed]
[2] 岳书冉, 胡瑞成. 肺弥散功能在慢性阻塞性肺疾病中的研究进展[J]. 临床肺科杂志, 2024, 29(6): 929-932.
[3] Okubo, Y., Takeuchi, T. and Takeuchi, S. (2016) A Case of Invasive Ductal Carcinoma Arising within Fibroadenoma. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 77, 763-767. [Google Scholar] [CrossRef] 
[4] Hegewald, M.J. (2009) Diffusing Capacity. Clinical Reviews in Allergy & Immunology, 37, 159-166. [Google Scholar] [CrossRef] [PubMed]
[5] Santus, P., Radovanovic, D., Balzano, G., Pecchiari, M., Raccanelli, R., Sarno, N., et al. (2016) Improvements in Lung Diffusion Capacity Following Pulmonary Rehabilitation in COPD with and without Ventilation Inhomogeneity. Respiration, 92, 295-307. [Google Scholar] [CrossRef] [PubMed]
[6] Kovacs, G., Agusti, A., Barberà, J.A., Celli, B., Criner, G., Humbert, M., et al. (2018) Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype? American Journal of Respiratory and Critical Care Medicine, 198, 1000-1011. [Google Scholar] [CrossRef] [PubMed]
[7] Jankowich, M.D. and Rounds, S.I.S. (2012) Combined Pulmonary Fibrosis and Emphysema Syndrome. Chest, 141, 222-231. [Google Scholar] [CrossRef] [PubMed]
[8] DeCato, T.W. and Hegewald, M.J. (2021) Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD. Chest, 160, 389-390. [Google Scholar] [CrossRef] [PubMed]
[9] Steenbruggen, I. and de Jongh, F. (2017) Is Pulmonary Diffusion Capacity for Nitric Oxide (DL, NO) Likely to Become a Routine Pulmonary Function Test? Respiratory Physiology & Neurobiology, 241, 7-8. [Google Scholar] [CrossRef] [PubMed]
[10] Harvey, B., Strulovici-Barel, Y., Kaner, R.J., Sanders, A., Vincent, T.L., Mezey, J.G., et al. (2015) Risk of COPD with Obstruction in Active Smokers with Normal Spirometry and Reduced Diffusion Capacity. European Respiratory Journal, 46, 1589-1597. [Google Scholar] [CrossRef] [PubMed]
[11] Fazleen, A. and Wilkinson, T. (2020) Early COPD: Current Evidence for Diagnosis and Management. Therapeutic Advances in Respiratory Disease, 14, 1-13. [Google Scholar] [CrossRef] [PubMed]
[12] Kahnert, K., Jörres, R.A., Behr, J. and Welte, T. (2023) The Diagnosis and Treatment of COPD and Its Comorbidities. Deutsches Ärzteblatt international, 120, 434-444. [Google Scholar] [CrossRef] 
[13] Hurst, J.R. and Wedzicha, J.A. (2007) What Is (and What Is Not) a COPD Exacerbation: Thoughts from the New GOLD Guidelines. Thorax, 62, 198-199. [Google Scholar] [CrossRef] [PubMed]
[14] Wei, X., Ma, Z., Yu, N., Ren, J., Jin, C., Mi, J., et al. (2017) Risk Factors Predict Frequent Hospitalization in Patients with Acute Exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 121-129. [Google Scholar] [CrossRef] [PubMed]
[15] Choi, J., Sim, J.K., Oh, J.Y., Lee, Y.S., Hur, G.Y., Lee, S.Y., et al. (2021) Prognostic Marker for Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Analysis of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Forced Expiratory Volume in One Second (FEV1). BMC Pulmonary Medicine, 21, Article No. 152. [Google Scholar] [CrossRef] [PubMed]
[16] Vogelmeier, C.F., Román-Rodríguez, M., Singh, D., Han, M.K., Rodríguez-Roisin, R. and Ferguson, G.T. (2020) Goals of COPD Treatment: Focus on Symptoms and Exacerbations. Respiratory Medicine, 166, Article ID: 105938. [Google Scholar] [CrossRef] [PubMed]
[17] Tan, D.J., Lodge, C.J., Walters, E.H., Bui, D.S., Pham, J., Lowe, A.J., et al. (2024) Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-Based Cohort Study. American Journal of Respiratory and Critical Care Medicine, 209, 1431-1440. [Google Scholar] [CrossRef] [PubMed]
[18] Tantucci, C. and Modina, D. (2012) Lung Function Decline in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 7, 95-99. [Google Scholar] [CrossRef] [PubMed]

为你推荐